Olivier Reynard researcher
Reynard, Olivier, 1979-....
VIAF ID: 296148389451110711400 (Personal)
Permalink: http://viaf.org/viaf/296148389451110711400
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs. | |
Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP. | |
Characterization of the Unconventional Secretion of the Ebola Matrix Protein VP40. | |
Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release. | |
Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry. | |
Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. | |
Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. | |
Entry of Ebola Virus is an Asynchronous Process. | |
Filovirus proteins for antiviral drug discovery: Structure/function of proteins involved in assembly and budding. | |
A first outbreak of Ebola virus in West Africa | |
Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. | |
[Haemostasis dysregulation in filovirus infections]. | |
Human transmission of Ebola virus. | |
Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. | |
In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity. | |
Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction | |
Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection. | |
Mannoside Glycolipid Conjugates Display Antiviral Activity Against Ebola Virus | |
Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1. | |
Méthyltransférases des filovirus et autres mononégavirus : caractérisation, originalités et drug design | |
Modeling Ebolavirus Budding with Virus Like Particles | |
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody | |
RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor. | |
Role of VP30 phosphorylation in the Ebola virus replication cycle. | |
Study of Ebola virus glycoprotéin’s role in ebola virus entry and developpement of novel therapeutics. | |
VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. | |
VP40 octamers are essential for Ebola virus replication. |